Home Clinical Topics FDA approves new treatment for eczema

FDA approves new treatment for eczema

On Dec. 14, the Food and Drug Administration (FDA) approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema in patients 2 years of age and older. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here